Edvan de Queiroz Crusoé

8PUBLICATIONS
66CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyHaematological tumoursRegenerative medicine (incl. stem cells)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 12, 2026
Daratumumab-Bortezomib-Cyclophosphamide-Dexamethasone in Newly Diagnosed Amyloidosis: ANDROMEDA Final Survival Analysis.

|Dec 06, 2025
Survival impact of anti-CD38-based quadruplet regimens in transplant-ineligible newly diagnosed multiple myeloma: a network meta-analysis and reconstructed individual patient data meta-analysis.

João Tadeu Damian Souto Filho, Lucas Oliveira Cantadori, Edvan de Queiroz Crusoe

|Aug 19, 2025
Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysis.

Andrew Spencer, Maria Gavriatopoulou, Daniel Coriu

|May 07, 2025
Challenges in the integration of palliative care for patients with hematologic malignancies: an analysis of the surprise question in a prospective cohort study.

Alini Maria Orathes Ponte Silva, Diego Lopes Paim Miranda, David Pereira Ferreira

|Mar 14, 2025
Daratumumab-based quadruplet versus triplet induction regimens in transplant-eligible newly diagnosed multiple myeloma: a systematic review and meta-analysis.

João Tadeu Damian Souto Filho, Lucas Oliveira Cantadori, Edvan de Queiroz Crusoe

|Dec 10, 2024
Health care systems as determinants of outcomes in multiple myeloma: final results from the Latin American MYLACRE study.

Vania Hungria, Rafael Gaiolla, Kenny Galvez

Pageof 2

Frequent Collaborators

4 joint publications

Vania Hungria

3 joint publications

Angelo Maiolino

2 joint publications

Alini Maria Orathes Ponte Silva

2 joint publications

João Tadeu Damian Souto Filho